| 1 |
monoclonal antibodies
(14143 times)
|
Allergy and Immunology
(2630 times)
|
ELISA (661 times)
LPS (188 times)
ADCC (183 times)
|
1981 Reactivity of monoclonal antibodies against intermediate filament proteins during embryonic development.
|
| 2 |
monoclonal Abs
(69 times)
|
Allergy and Immunology
(18 times)
|
Abs (38 times)
Ab (18 times)
Env (7 times)
|
1999 Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection.
|
| 3 |
anti-MHC antibodies
(2 times)
|
Genetics
(1 time)
|
ENU (1 time)
MHC (1 time)
MIF (1 time)
|
1988 Detection of new MHC mutations in mice by skin grafting, tumor transplantation and monoclonal antibodies: a comparison.
|
| 4 |
anti-NDV-monoclonal antibodies
(2 times)
|
Microbiology
(1 time)
|
IFN (1 time)
|
1994 More than one component of the Newcastle disease virus particle is capable of interferon induction.
|
| 5 |
monoclonal anti-nucleosome antibodies
(2 times)
|
Nephrology
(1 time)
|
DSA-HEP (1 time)
Hep (1 time)
HS (1 time)
|
1996 Heparin and heparinoids prevent the binding of immune complexes containing nucleosomal antigens to the GBM and delay nephritis in MRL/lpr mice.
|
| 6 |
monoclonal antibody therapies
(2 times)
|
Medicine
(1 time)
|
ADA (1 time)
CMs (1 time)
ER (1 time)
|
2016 Posttranslational Modifications and the Immunogenicity of Biotherapeutics.
|
| 7 |
monoclonal therapeutic antibodies
(2 times)
|
Flow Cytometry
(1 time)
|
ABC (1 time)
ADCP (1 time)
CPI (1 time)
|
2017 Oxidation of M252 but not M428 in hu-IgG1 is responsible for decreased binding to and activation of hu-FcgammaRIIa (His131).
|
| 8 |
monoclonal, IgG class antibodies
(2 times)
|
Biochemistry
(1 time)
|
---
|
1994 Kinetics of Fc epsilon RI dimer formation by specific monoclonal antibodies on mast cells.
|
| 9 |
murine antibodies
(2 times)
|
Endocrinology
(1 time)
|
ELISA (1 time)
NGAL (1 time)
SDS-PAGE (1 time)
|
2002 Cross-reactivity of a monoclonal antibody to the amino terminal region of thyrotropin receptor with the serum protein alpha(1)-antitrypsin.
|
| 10 |
Immunoconjugates--monoclonal antibodies
(1 time)
|
Biotechnology
(1 time)
|
---
|
2005 Arming antibodies: prospects and challenges for immunoconjugates.
|
| 11 |
marketed therapeutic antibodies
(1 time)
|
Biotechnology
(1 time)
|
ADCC (1 time)
CHO (1 time)
GDP (1 time)
|
2020 Generation of FX-/- and Gmds-/- CHOZN host cell lines for the production of afucosylated therapeutic antibodies.
|
| 12 |
mechanisms by which therapeutic antibodies
(1 time)
|
Neoplasms
(1 time)
|
ADCC (1 time)
Fc (1 time)
NK (1 time)
|
2017 Obinutuzumab-mediated high-affinity ligation of FcgammaRIIIA/CD16 primes NK cells for IFNgamma production.
|
| 13 |
Methods: We generated a panel ofmonoclonal antibodies
(1 time)
|
|
HCV (1 time)
|
2017 A new panel of epitope mapped monoclonal antibodies recognising the prototypical tetraspanin CD81.
|
| 14 |
milli absorbances
(1 time)
|
Clinical Laboratory Techniques
(1 time)
|
---
|
2019 Estimation of lipemia interference with automated HIL-test on d-dimer ACL TOP 50 series analysis - reveals a higher cut-off than manufacturer's recommendations.
|
| 15 |
milliabsorbance units
(1 time)
|
Hematology
(1 time)
|
APTT (1 time)
dRVVT (1 time)
HIL (1 time)
|
2021 Revisiting the effects of spectral interfering substances in optical end-point coagulation assays.
|
| 16 |
molecule antibodies
(1 time)
|
General Surgery
(1 time)
|
anti-LECAM-1 (1 time)
MP (1 time)
NO (1 time)
|
1997 Effect of antileukocyte adhesion molecule antibodies, nitric oxide synthase inhibitor, and corticosteroids on endotoxin shock in mice.
|
| 17 |
molecules and two half-lives for immunoglobulins
(1 time)
|
Clinical Medicine
(1 time)
|
CTFG (1 time)
FDA (1 time)
ICH (1 time)
|
2016 Clinical trial considerations on male contraception and collection of pregnancy information from female partner: update.
|
| 18 |
monoclonal anti-aminopeptidase A antibodies
(1 time)
|
Nephrology
(1 time)
|
---
|
1999 Induction of albuminuria in mice: synergistic effect of two monoclonal antibodies directed to different domains of aminopeptidase A.
|
| 19 |
monoclonal anti-class I HLA antibodies
(1 time)
|
Allergy and Immunology
(1 time)
|
SAFB (1 time)
SPR (1 time)
T-FCXM (1 time)
|
2019 Measuring anti-HLA antibody active concentration and affinity by surface plasmon resonance: Comparison with the luminex single antigen flow beads and T-cell flow cytometry crossmatch results.
|
| 20 |
monoclonal anti-hemolysin antibodies
(1 time)
|
Biochemistry
(1 time)
|
---
|
1995 Binding of antibodies to functional epitopes on the pore formed by Escherichia coli hemolysin in cells and model membranes.
|
| 21 |
monoclonal anti-mouse laminin antibodies
(1 time)
|
Nephrology
(1 time)
|
GMB (1 time)
TBM (1 time)
|
1993 Laminin distribution in developing glomerular basement membranes.
|
| 22 |
monoclonal antibodies and Fc fusion proteins
(1 time)
|
Biomedical Engineering
(1 time)
|
---
|
2006 Downstream processing of monoclonal antibodies--application of platform approaches.
|
| 23 |
monoclonal antibodies and Fc-containing derivatives
(1 time)
|
Drug Therapy
(1 time)
|
PBPK (1 time)
TMDD (1 time)
|
2014 Simulation of monoclonal antibody pharmacokinetics in humans using a minimal physiologically based model.
|
| 24 |
monoclonal antibodies labeling
(1 time)
|
Chemistry
(1 time)
|
AFM (1 time)
HG (1 time)
SB (1 time)
|
2021 Sodium bicarbonate reduces the cooked hardness of lotus rhizome via side chain rearrangement and pectin degradation.
|
| 25 |
Monoclonal antibodies to hTSHR
(1 time)
|
Biochemistry
(1 time)
|
hTSHr (1 time)
|
2017 In silico and in vitro analysis of cross-reactivity between Yersinia pseudotuberculosis OmpF porin and thyroid-stimulating hormone receptor.
|
| 26 |
monoclonal antibody biologics
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
2018 From mother to baby: antenatal exposure to monoclonal antibody biologics.
|
| 27 |
monoclonal antibody drugs
(1 time)
|
Drug Therapy
(1 time)
|
IgG (1 time)
PBPK (1 time)
|
2012 Evaluation of a catenary PBPK model for predicting the in vivo disposition of mAbs engineered for high-affinity binding to FcRn.
|
| 28 |
monoclonal competitor antibodies
(1 time)
|
Virology
(1 time)
|
AIVs (1 time)
cELISAs (1 time)
HI (1 time)
|
2011 Broad spectrum reactivity versus subtype specificity-trade-offs in serodiagnosis of influenza A virus infections by competitive ELISA.
|
| 29 |
Monoclonal IgG and IgM antibodies
(1 time)
|
Science
(1 time)
|
GalTase (1 time)
|
1984 Characterization of monoclonal antibodies to serum galactosyltransferase.
|
| 30 |
monoclonal immunoglobulins
(1 time)
|
Chemistry Techniques, Analytical
(1 time)
|
ESI-Q-TOF MS (1 time)
LC-MS (1 time)
TDM (1 time)
|
2016 Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis.
|
| 31 |
monoclonal TSHR-Abs
(1 time)
|
|
GD (1 time)
TBIIs (1 time)
TSAbs (1 time)
|
2019 Experimental Reproduction of Dynamic Fluctuation of TSH Receptor-Binding Antibodies Between Stimulation and Inhibition.
|
| 32 |
mouse anti-human B7-H4 monoclonal antibodies
(1 time)
|
Allergy and Immunology
(1 time)
|
ELISA (1 time)
GD (1 time)
sB7-H4 (1 time)
|
2021 Establishment of a novel double-monoclonal antibody sandwich enzyme-linked immunosorbent assay (ELISA): tool for human B7-H4 detection in autoimmune diseases.
|
| 33 |
mouse antibodies
(1 time)
|
Medicine
(1 time)
|
VEGF (1 time)
|
2013 The role of VEGF in melanoma progression.
|
| 34 |
mouse IgG-antibodies
(1 time)
|
Biochemistry
(1 time)
|
DNP (1 time)
|
1993 Cooperativity in the antibody binding to surface-adsorbed antigen.
|
| 35 |
multiple anti-DEspR blocking antibodies
(1 time)
|
Neoplasms
(1 time)
|
CDX (1 time)
CSCs (1 time)
cscTCs (1 time)
|
2021 Humanized anti-DEspR IgG4S228P antibody increases overall survival in a pancreatic cancer stem cell-xenograft peritoneal carcinomatosis ratnu/nu model.
|
| 36 |
multiple autoantibodies
(1 time)
|
Endocrinology
(1 time)
|
GADA (1 time)
IA-2A (1 time)
IAA (1 time)
|
2019 The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening.
|
A Search Service for Abbreviation / Long Form